James X. Gray

Suggest Changes
Learn More
BACKGROUND Given its prognostic value, there is renewed interest in molecular staging in non-Hodgkin's lymphoma (NHL) using immunoglobulin heavy and light chain (IgH, IgL) gene rearrangements. AIMS(More)
  • 1